Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol
about
The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathwayFunctional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-IIHigh-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and AtherosclerosisFoxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein MCubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosisTriglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes.Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney diseaseDelayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiencyInsulin resistance and cardiovascular disease.Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementChylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.High-density-lipoprotein cholesterol and atherosclerosis.Triglycerides and heart disease: still a hypothesis?Lipid profile of type 2 diabetic and hypertensive patients in the jamaican population.Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones.Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier DiseaseIncreased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrationsEffluxed lipids: Tangier Island's latest export.Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in HumansThematic review series: patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans?Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes.Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mousePotent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome.Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.Therapies for diabetic dyslipidaemia.Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.Carboxyl-terminal domain truncation alters apolipoprotein A-I in vivo catabolism.Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.Imaging apolipoprotein AI in vivo.Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism.Apolipoprotein A-I, A-II, and VLDL-B-100 metabolism in men: comparison of a low-fat diet and a high-monounsaturated fatty acid diet.High-density lipoprotein apolipoprotein A-I kinetics in obesity.Nutraceutical approaches to metabolic syndrome.Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.
P2860
Q22010685-FF610D09-71F3-4600-B7E0-77E40DD7FBB1Q24312351-8513B212-C095-4674-A7D2-42F169599868Q26746080-99598374-2002-42AC-AD29-F876EA8EC39CQ28594461-7FF37A7E-3F37-4F01-A6B8-88E1FB98F187Q28645882-B866166F-B512-4FCC-8993-9B0FC81C166EQ33849302-F05984E5-BAD2-4170-862E-36986C3952BEQ33887783-8EBD034B-882B-4011-8397-ACD1769E9FD0Q33901943-9BF7C86C-B161-4A27-9AEF-BE5F72DAD44CQ33903940-D691B53B-B47D-4B1F-B606-806D59224C7FQ34011027-DB8BD480-D09F-4E43-BEC0-274D67EA39CDQ34181381-6B400945-5D79-4D8F-B5AC-28C4ABC9BA19Q34352004-CEBCFE59-4355-445F-9512-64859D5352F1Q34707124-047C2C0B-DE3C-437A-A11C-95CA10BFFB11Q35120360-C6171EA4-5B2A-4746-870E-7C8D1FEC2F16Q35137994-98331DDD-47C9-4537-9DC8-A69C41030B9CQ35590298-820C0413-7DD8-45DD-ADEB-EBBD49DFCC14Q35747749-29F7FAF2-7332-40A8-B5FE-59B1EAC52F38Q35749982-9C174E1B-51B8-41CA-B206-42C77455C5D8Q35751599-A623B4A2-BFE1-4885-A28F-69E4DFF89D63Q36173368-540C987D-DB75-4D54-9484-94F18A7524F5Q36403156-9CD3E95A-8470-401B-B5E0-EC4992F21F03Q36473656-B23DB346-557A-4284-810C-C7C92E9368D3Q36573819-BF72AEF4-3161-44B6-AC4C-1AD9A12CB346Q37013499-20F44DC6-9588-45CD-82E6-38F310F8CC76Q37222407-79B6EE3F-E55F-490D-8114-6672ACF7D7DEQ37353135-62AA36B0-0A15-410A-B2EF-4A32A10214B8Q37354180-B033F32D-0AEF-4DBE-8DB5-1387DBFC5D12Q37825945-42B7C560-E3F5-466C-BC9F-31361D5E3648Q38291709-EB256F73-88EA-4513-9AB0-E0FFBCC1ED66Q38297747-E5FC49D8-CE03-4FFE-941D-E319D134BF32Q38328590-6B90CE36-5810-46D0-8D18-3537B01A5E8DQ40164897-E538FA17-02A6-4A95-ABF8-22A8CA098535Q41571785-0A985E89-C6A4-49D0-89D4-679F0CF17E79Q41953670-3A39D867-0A57-45FD-82D8-A0B58235A411Q44516309-3032D7DF-0E95-40BD-BC1C-71894591D701Q45041063-5F9779ED-AD12-48ED-B500-B5526EABD3E9Q46564730-8348834C-DBC6-4D22-9294-773BF37A01F3Q47979569-B4563F81-E406-4182-9532-DAD350291740Q50097160-DD134526-B01C-468E-B169-65C810DDF9A1Q50118982-83D158F1-54F1-4B95-BD4E-36EA68FFA6FB
P2860
Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Increased plasma and renal cle ...... ensity lipoprotein cholesterol
@ast
Increased plasma and renal cle ...... ensity lipoprotein cholesterol
@en
type
label
Increased plasma and renal cle ...... ensity lipoprotein cholesterol
@ast
Increased plasma and renal cle ...... ensity lipoprotein cholesterol
@en
prefLabel
Increased plasma and renal cle ...... ensity lipoprotein cholesterol
@ast
Increased plasma and renal cle ...... ensity lipoprotein cholesterol
@en
P2093
P2860
P356
P1476
Increased plasma and renal cle ...... ensity lipoprotein cholesterol
@en
P2093
B S Horowitz
H N Ginsberg
I J Goldberg
R Ramakrishnan
P2860
P304
P356
10.1172/JCI116384
P407
P577
1993-04-01T00:00:00Z